Argus Downgrades Novo Nordisk (NVO) to Hold
Tweet
Share
E-mail
Get Alerts NVO Hot Sheet
Price: $46.74 +1.30%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Argus analyst John Eade downgraded Novo Nordisk (NYSE: NVO) from Buy to Hold.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $47.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- enVVeno Medical (NVNO) files $100M mixed shelf
- Sigma Lithium resumes full operations after signing TAC agreement
Create E-mail Alert Related Categories
DowngradesRelated Entities
Argus, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
